Reports

Drug name	NICE TAs	Comments
Idarucizumab 2.5g/250ml solution for injection/infusion		When rapid reversal of Dabigatran anticoagulant effect is required
Idursulfase concentrate for infusion		NHSE commissioned.
Ifosfamide infusion		For hospital use only
Iloprost nebules		Hospital use only. NHS England commissioned.
Imatinib (Glivec®)	TA70 - Guidance on the use of imatinib for chronic myeloid leukaemia (partially updated by TA241 and TA251) TA86 - Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours TA326 - Imatinib for the adjuvant treatment of gastrointestinal stromal tumours TA209 - Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours TA426 - Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia TA241 - Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia (CML) (part review of NICE technology appraisal guidance 70), and dasatinib and nilotinib for people with CML for whom treatment with imatinib has failed because of intolerance	Off-label use for melanoma with responsive c-KIT mutation
Imiglucerase injection		NHSE commissioned.
Imipramine tablets		Specialist initiation only
Inclisiran (Leqvio®)	TA733 - Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia	BSSE APC prescribing information regarding Inclisiran
Indapamide tablets		2.5mg tablets only
Indometacin capsules		For gout and resistant case

University Hospitals Birmingham NHS Foundation Trust